<DOC>
	<DOCNO>NCT01581411</DOCNO>
	<brief_summary>1 . Study hypothesis : Injection t-PA , thrombolytic drug ( clot bust medicine ) ophthalmic artery ( blood vessel feed eye ) , patient recent severe central retinal vein occlusion , may reopen central retinal vein improve retinal blood flow , may turn improve visual acuity prevent long-term complication disease . 2 . Experimental intervention : An outpatient procedure ophthalmic artery selective catheterize ( small plastic tube call microcatheter introduce artery leg ) infuse t-PA two hour .</brief_summary>
	<brief_title>Intra-arterial Thrombolysis Severe Recent Central Retinal Vein Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Plasminogen</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Severe CRVO diagnose presence relative afferent papillary defect ( RAPD ) visual acuity 20/200 bad Symptom onset within 2 week Age &gt; 18 year old Patient able willing give inform consent Futile intervention : light perception , absence perfusion fluorescein angiography . Contraindication thrombolysis : active recent ( 1 month ) internal bleeding , cerebrovascular accident , major organ surgery , major trauma ; intracranial neoplasm vascular malformation , know bleed diathesis , severe uncontrolled arterial hypertension , pregnancy ( woman childbearing age must negative serum pregnancy test ) , condition opinion investigator would preclude use thrombolytic agent . Highrisk catheterization : history stroke TIA ; carotid bruit know carotid occlusive disease ; cardiovascular condition opinion investigator may increase risk catheterization ophthalmic artery . Ocular criterion : Intraocular neovascularization ( secondary etiology ) , vitreous hemorrhage , inflammatory eye disease , condition precludes fundus photography fluorescein angiography .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>central retinal vein occlusion</keyword>
	<keyword>macular edema</keyword>
	<keyword>vision loss</keyword>
	<keyword>rtelative afferent papillary defect</keyword>
</DOC>